Opportunity Analysis for Biosimilars - South Korea

Opportunity Analysis for Biosimilars - South Korea

Patent Expiry of Biologics to Provide Potential Growth for Biosimilars

RELEASE DATE
05-Sep-2012
REGION
Asia Pacific
Research Code: P601-01-00-00-00
SKU: HC02369-AP-MR_08491
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02369-AP-MR_08491

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service presents an overview of the South Korean biosimilars market and analyzes the opportunities that lay ahead for different stakeholders in the development, manufacturing, and commercialization of biosimilars. This service divides the market into therapeutic proteins and monoclonal antibodies. Further, it aims to present an overview of the global biosimilars market and covers impending patent expiries for biologics, regulatory guidelines, pipeline data, and important participants in the market. Moreover, key market challenges, drivers, and restraints are discussed. The forecast period extends through 2015, with a base year of 2010.

Table of Contents

Opportunity Analysis

  • South Korea Biosimilars Market
Related Research
This research service presents an overview of the South Korean biosimilars market and analyzes the opportunities that lay ahead for different stakeholders in the development, manufacturing, and commercialization of biosimilars. This service divides the market into therapeutic proteins and monoclonal antibodies. Further, it aims to present an overview of the global biosimilars market and covers impending patent expiries for biologics, regulatory guidelines, pipeline data, and important participants in the market. Moreover, key market challenges, drivers, and restraints are discussed. The forecast period extends through 2015, with a base year of 2010.
More Information
No Index No
Podcast No
Author Poornima Srinivasan
Industries Healthcare
WIP Number P601-01-00-00-00
Is Prebook No